Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 3Active not recruiting 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 10Breast Neoplasms 10Uterine Cervical Neoplasms 9Lymphoma 8Squamous Cell Carcinoma of Head and Neck 7Prostatic Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Head and Neck Neoplasms 7Lymphoma, Large B-Cell, Diffuse 6Sarcoma 5Melanoma 5Lymphoma, Follicular 5Leukemia 5Colorectal Neoplasms 5Adenocarcinoma of Lung 5Small Cell Lung Carcinoma 4Rectal Neoplasms 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Glioblastoma 4Central Nervous System Neoplasms 4Carcinoma, Hepatocellular 4Burkitt Lymphoma 4Ovarian Neoplasms 3Neoplasms 3

Interventions

Petrolatum 2Fluorouracil 2trametinib 1talimogene laherparepvec 1sargramostim 1reolysin 1pimonidazole 1pembrolizumab 1fluoromisonidazole 1dabrafenib 1Trimethoprim, Sulfamethoxazole Drug Combination 1Surgical Procedures, Operative 1Sugars 1Radiotherapy 1Radiation 1Povidone-Iodine 1Melphalan 1Granulocyte-Macrophage Colony-Stimulating Factor 1Erlotinib Hydrochloride 1Clindamycin 1Clarithromycin 1Cephalexin 1Azithromycin 1Anti-Bacterial Agents 1Amoxicillin 13-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Skin Neoplasms × Radiotherapy × Clear all
NCT01465815 2014-11-19

Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)

OHSU Knight Cancer Institute

Phase 1/2 Withdrawn
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡